Need professional-grade analysis? Visit stockanalysis.com
$3.85B
N/A
114
N/A
Centessa Pharmaceuticals PLC ADR (CNTA) trades on United States in USD. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at $39.49, down 0.43% from the previous close.
Over the past year, CNTA has traded between a low of $11.86 and a high of $39.76. The stock has gained 203.1% over this period. It is currently 233.0% above its 52-week low.
Centessa Pharmaceuticals PLC ADR has a market capitalization of $3.85B.
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
Side-by-side comparison against top Healthcare peers.